Brainsway (BWAY) Cash from Operations Growth (1y) (2019 - 2026)
Brainsway (BWAY) Cash from Operations Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 129.01 Bn | 126.14 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 48.40 Bn | 44.73 Bn | 1.29 Bn | -84.38% |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn | 185.96% |
| 7 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn | 16.00% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.46 Bn | 22.33 Bn | 2.07 Bn | 122.43% |
| 10 | Brainsway | 588.70 Mn | 528.93 Mn | 11.68 Mn | -76.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -76.63% |
| Dec 31, 2025 | -121.72% |
| Sep 30, 2025 | -39.16% |
| Jun 30, 2025 | 818.62% |
| Mar 31, 2025 | 57.65% |
| Dec 31, 2024 | 41.23% |
| Sep 30, 2024 | 67.99% |
| Jun 30, 2024 | 35.48% |
| Mar 31, 2024 | 189.75% |
| Dec 31, 2023 | 210.30% |
| Sep 30, 2023 | 161.00% |
| Jun 30, 2023 | 143.15% |
| Mar 31, 2023 | -18.55% |
| Dec 31, 2022 | -162.76% |
| Sep 30, 2022 | -300.54% |
| Jun 30, 2022 | -26.77% |
| Mar 31, 2022 | -848.25% |
| Dec 31, 2021 | 117.93% |
| Sep 30, 2021 | 50.22% |
| Jun 30, 2021 | -395.29% |